Paper3203043
The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
van Harten J and 4 others. Br J Clin Pharmacol, 1988. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man. Papers, record 3203043. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3203043
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemodynamics | Major topic |
| Nifedipine | Major topic |
| Vasodilator Agents | Major topic |
| Adsorption | |
| Adult | |
| Female | |
| Humans | |
| Indocyanine Green | |
| Infusions, Intravenous | |
| Liver Circulation | |
| Male | |
| Nisoldipine |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7097514 | Model-independent steady-state volume of distribution. | J Pharm Sci | 1982 | https://conductscience.org/library/papers/7097514 | PubMed |
| 2 | 3443667 | Gas chromatographic determination of nisoldipine and one of its metabolites in plasma. | J Chromatogr | 1987 | https://conductscience.org/library/papers/3443667 | PubMed |
| 3 | 6419762 | Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6419762 | PubMed |
| 4 | 6491984 | Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine. | J Pharmacol Exp Ther | 1984 | https://conductscience.org/library/papers/6491984 | PubMed |
| 5 | 6518345 | Energy conservation by nisoldipine in ischaemic heart. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6518345 | PubMed |
| 6 | 3968639 | Effects of nisoldipine on cardiocirculatory dynamics and cardiac output distribution in conscious rats at rest and during treadmill exercise. | J Pharmacol Exp Ther | 1985 | https://conductscience.org/library/papers/3968639 | PubMed |
| 7 | 3894474 | A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects. | J Am Coll Cardiol | 1985 | https://conductscience.org/library/papers/3894474 | PubMed |
| 8 | 4025130 | Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure. | Am Heart J | 1985 | https://conductscience.org/library/papers/4025130 | PubMed |
| 9 | 4041329 | Verapamil pharmacokinetics and apparent hepatic and renal blood flow. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4041329 | PubMed |
| 10 | 4041344 | The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4041344 | PubMed |
| 11 | 4054203 | The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4054203 | PubMed |
| 12 | 3958095 | Determination of nimodipine by gas chromatography using electron-capture detection; external factors influencing nimodipine concentrations during intravenous administration. | J Chromatogr | 1986 | https://conductscience.org/library/papers/3958095 | PubMed |
| 13 | 3731687 | Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy. | Clin Pharmacol Ther | 1986 | https://conductscience.org/library/papers/3731687 | PubMed |
| 14 | 3802702 | Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. | Clin Pharmacol Ther | 1987 | https://conductscience.org/library/papers/3802702 | PubMed |
| 15 | 3606929 | Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3606929 | PubMed |
| 16 | 6684444 | Hemodynamic effects of nisoldipine in chronic congestive heart failure. | Arzneimittelforschung | 1983 | https://conductscience.org/library/papers/6684444 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24735761 | Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships. | J Pharm Pharm Sci | 2014 | https://conductscience.org/library/papers/24735761 | PubMed |
| 9833602 | The influence of drug input rate on the development of tolerance to frusemide. | Br J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9833602 | PubMed |
| 9784933 | Clinical pharmacokinetics of nisoldipine coat-core. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9784933 | PubMed |
| 8162657 | Influence of drug formulation on drug concentration-effect relationships. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/8162657 | PubMed |
| 8145128 | A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers. | J Pharmacokinet Biopharm | 1993 | https://conductscience.org/library/papers/8145128 | PubMed |
| 8005183 | Influence of input rates on (+/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers. | Eur J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/8005183 | PubMed |
| 3065058 | Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. | Drugs | 1988 | https://conductscience.org/library/papers/3065058 | PubMed |
| 2757881 | The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2757881 | PubMed |
| 2706880 | Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2706880 | PubMed |
| 2488100 | Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2488100 | PubMed |
| 2181524 | The use of kinetic-dynamic interactions in the evaluation of drugs. | Psychopharmacology (Berl) | 1990 | https://conductscience.org/library/papers/2181524 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3203043
GET https://conductscience.org/api/papers/v1/3203043/authors